Markets India

Prasol Chemicals, a specialty chemicals manufacturer, raised nearly Rs 150 crore from anchor investors ahead of its Rs 500-crore IPO, scheduled to open on September 8. The allocation of 22.19 lakh equity shares at Rs 676 per share to institutional investors signals strong demand for the offering, which aims to fund debt repayment and operational needs.

Prasol Chemicals Ltd has secured Rs 150 crore from anchor investors, including Tata Mutual Fund, Kotak Mahindra Mutual Fund, and Aditya Birla Sun Life Insurance, ahead of its Rs 500-crore IPO. The allocation of 22.19 lakh shares at Rs 676 per share totaled Rs 149.99 crore, with over 10 lakh shares (45.34%) allocated to domestic mutual funds. The IPO, opening on September 8, offers a price band of Rs 643–676 per share, reflecting market confidence in the company’s valuation. The public offer includes a fresh issue of Rs 80 crore and an offer-for-sale (OFS) of Rs 420 crore by existing shareholders.

The IPO’s allocation strategy underscores the company’s focus on strengthening its capital structure. Proceeds from the fresh issue will address debt obligations and working capital requirements, while the OFS component may dilute existing shareholders’ stakes. Prasol Chemicals, which produces specialty chemicals used in pharmaceuticals, agrochemicals, and personal care products, positions itself to benefit from growing demand in high-margin sectors. The strong institutional participation suggests a favorable reception for the offering, though public subscription success remains critical.

Anchor investors, including Edelweiss Mutual Fund and ITI Mutual Fund, have committed to the allocation, signaling confidence in Prasol Chemicals’ growth trajectory. The company’s forward-integrated manufacturing model, which spans acetone and phosphorus-based chemicals, enhances its competitive edge in the specialty chemicals sector. However, the OFS component could impact long-term equity valuation, particularly if the public subscription falls short of targets. Competitors in the pharmaceutical and agrochemical intermediates space may face intensified rivalry as Prasol expands its market presence.

The IPO subscription period runs from September 8 to September 10, with the public offer comprising a fresh issue of Rs 80 crore and an OFS of Rs 420 crore. The final price band and subscription results will determine the IPO’s market reception and Prasol Chemicals’ capital-raising success.

Prasol Chemicals’ Rs 150 crore pre-IPO fundraising highlights investor confidence in its specialty chemicals business, but the IPO’s success hinges on public subscription and market conditions. The company’s focus on high-demand intermediates presents growth potential, though the OFS component may affect existing shareholders’ equity.

Topics: Finance, Markets, IPO, Chemicals, Investment, India, Corporate Finance, Equity, Public Offering

#PrasolChemicals #IPO #AnchorInvestors #Rs150Crore #SpecialtyChemicals #IndiaMarket #CorporateFinance #Equity #PublicOffering #DebtRepayment

Source: ET Markets